Formaggio N et al. [25] mentioned that OCT4 contributes to the dedifferentiation of PCa into an AR-negative state, promoting neuroendocrine differentiation and reducing sensitivity to AR-targeted therapies. Here, AR is linked to posterior cortical atrophy.